![moa of glp-1 agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review glp-1_analogs [TUSOM | Pharmwiki]](https://s3.amazonaws.com/production.scholastica/public/attachments/bd59d6e4-c76b-4a0f-853f-f18e54c05fbd/large/figure_2._principal_mechanisms_lead_by_glp-1r_activation.png)
moa of glp-1 agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review glp-1_analogs [TUSOM | Pharmwiki]
Description
GLP-1 stimulates insulin ...
![moa of glp-1 agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Some studies, though not conclusive, predict that tirzepatide may in fact be more potent than GLP-1 RAs at reducing weight
![moa of glp-1 agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/371461642/figure/fig2/AS:11431281210340311@1702043944953/Mechanisms-of-action-of-GLP-1RA.jpg)
Glucagon-like peptide-1 (GLP-1) agonists are very popular and useful medications for the treatment of type 2 diabetes mellitus and obesity
![moa of glp-1 agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review glp-1_analogs [TUSOM | Pharmwiki]](https://www.frontiersin.org/files/Articles/1085799/xml-images/fendo-14-1085799-g001.webp)
The FDA has also warned about risks during surgery because the drug slows digestion
![moa of glp-1 agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review glp-1_analogs [TUSOM | Pharmwiki]](https://www.biochempeg.com/usr/uploads/3/202209/Biological-actions-of%20-GLP-1.png)
Author's Bio: Katie Bailey, MS, RD, LD, FNCHi everyone
![moa of glp-1 agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00592-024-02300-6/MediaObjects/592_2024_2300_Fig1_HTML.png)
